Career News

Ottoline Leyser announced as new CEO at UK Research and Innovation

26.5.2020 | Eminent plant biologist and long-time science policy advisor will take over from Prof Sir Mark Walport.
Prof. Ottoline Leyser
Bild vergrößern
(© Ottoline Leyser)


Prof. Ottoline Leyser


One of the biggest players in research funding in the United Kingdom will see a change of leadership at the end of June. UK Research and Innovation (UKRI) administers research and innovative business funding from the science budget of the UK government, and since September 2019 it has been known that its current Chief Executive, Professor Sir Mark Walport, intended to retire in 2020. On May 14th it was announced that Professor Dame Ottoline Leyser FRS, an AcademiaNet member, will succeed him.


Prof Leyser is currently Professor of Plant Development at the University of Cambridge and the director of the Sainsbury Laboratory there, based in the Cambridge University Botanic Garden. Her work is focused on understanding plant hormones and the role they play in development, trying to answer questions about why some shoots produce branches and others do not, and what effect environmental input has on that decision-making. Though her career began at the University of Cambridge, where she received both her BA and her PhD, she has also held positions at both Indiana University and the University of York.


The appointment comes after more than a decade of accolades, such as the Royal Society Rosalind Franklin Award in 2007, the UK Genetics Society Medal in 2016 and the EMBO Women in Science Award in 2017. But outside academia she has also committed herself to science policy: She currently chairs the Royal Society’s expert advisory committee on science policy and she serves on the Council for Science and Technology, which advises the UK Prime Minister. This contribution was recognized when she was made Dame Commander of the Order of the British Empire (DBE) not only for services to plant science, but for science in society and equality and diversity in science.


Prof Leyser has said in a press release that she has seen first-hand the power of collaborative cultures to create solutions, and that she is looking forward to working with the UKRI team to pioneer new partnerships, develop innovative funding models and strengthen international collaboration. In particular, she will direct the delivery of the UK government’s ambition to increase investment in R&D to 2.4% of GDP by 2027.

  (© AcademiaNet)

More information

Testimonials

  1. Read what our members say about AcademiaNet.

Follow us

No more excuses!

  1. Please download the brochure "No more excuses" and read more about female experts in Europe, and about AcademiaNet.

News

  1. “We’re now living on a permanently polluted planet”

    Environmental historian Dr. Simone Müller talked to AcademiaNet about the roots of global unequal trade with hazardous waste material and what the personal and structural issues are that need to be solved to drive towards a sustainable future.

  2. Dr. Kathrin Rousk awarded €1.5 million ERC Starting Grant

    The funding will be used to investigate the vital process of nitrogen fixation in understudied, pristine environments.

  3. Gabriele Rippl and Anna Fontcuberta i Morral to join the SNSF National Research Council Presiding Board

    The two AcademiaNet members will help supervise and coordinate the work of the National Research Council.

  4. Françoise Combes awarded the 2020 CNRS Gold Medal

    The expert in galaxy evolution is honoured with the highest research award in France.

  5. On the significance of cortisol: Insights from Prof. Nina Henriette Uhlenhaut

    The numbers of Covid-19 cases are increasing worldwide. But in comparison to the beginning of the pandemic we are not completely clueless anymore—first treatment options for some of the most severely ill have emerged and surprisingly one of the drug candidates is an old friend: steroids in the form of Dexamethasone. We spoke with Professor Nina Henriette Uhlenhaut from the Technical University Munich and the Helmholtz Center in Munich, Germany, who researches what these steroids do in the body and why they have so many side-effects.